Volume 11, Issue 2 ( June 2019 2019)
Iranian Journal of Blood and Cancer 2019, 11(2): 72-74 |
Back to browse issues page
1- Thalassemia Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
2- Thalassemia Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran , dr.naderisorki@gmail.com
3- Associate Professor of Pathology, Immunogenetics Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
4- Assistant Professor of Interventional Radiology, Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
2- Thalassemia Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran , dr.naderisorki@gmail.com
3- Associate Professor of Pathology, Immunogenetics Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
4- Assistant Professor of Interventional Radiology, Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abstract: (3548 Views)
Hodgkin lymphoma (HL) as a malignant tumor presents with lymphadenopathy and systemic complaints. The origin of this tumor is mostly suggested to be B lymphocytes. There is a close relationship between autoimmunity and HL, but the mechanism of this immune syndromes is unclear. Immune thrombocytopenia (ITP) is the most common autoimmune syndrome which may present before, at the same time, and even after treatment of the HL. We present a case of ITP as a primary sign of relapse of HL in a 15-year-old boy after complete treatment of HL.
: Case report |
Subject:
Pediatric Hematology & Oncology
Received: 2019/07/27 | Accepted: 2019/07/29 | Published: 2019/08/17
Received: 2019/07/27 | Accepted: 2019/07/29 | Published: 2019/08/17
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |